Join us in exploring a new era in cellular medicine

At Rubius, our vision is to bring potentially life-changing cellular therapies to people living with rare metabolic and inflammatory disorders, cancer and autoimmune diseases. We call these potential medicines Red Cell Therapeutics™.

Learn About
Red Cell Therapeutics™
a Clinical Trial

Open Clinical Studies


Phenylketonuria (PKU)

Rubius Therapeutics is enrolling adults with PKU into a Phase 1 clinical trial to evaluate a new potential treatment option called RTX-134.

Learn More About the PKU Clinical Trial

Thank you

We will contact you about your submission